Precision Biosciences (DTIL) FCF Margin (2018 - 2026)
Precision Biosciences (DTIL) reported FCF Margin of 110.31% for Q1 2026, up 6580694.0% year-over-year from N/an in Q1 2025, and down 234.81% quarter-over-quarter from 32.95% in Q4 2025.
Precision Biosciences (DTIL) FCF Margin (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of FCF Margin data on file, last reported at 110.31% in Q1 2026.
- FCF Margin for Q1 2026 came in at 110.31%, up 6580694.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 130.38% (down 1552.0% YoY), and the FY2025 annual result was 192.41%, down 10697.0% from the prior year.
- FCF Margin retreated to 110.31% in Q1 2026 per DTIL's latest filing, from 32.95% in the prior quarter.
- Over five years, FCF Margin peaked at 381.58% in Q3 2022 and troughed at 117461.54% in Q3 2025.
- A 5-year average of 17789.4% and a median of 212.07% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2025 and 2026: FCF Margin plunged 11642838 bps in 2025, then jumped 6580694 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 212.07% in 2022, then surged by 44 bps to 119.31% in 2023, then tumbled by 2367 bps to 2943.57% in 2024, then jumped by 99 bps to 32.95% in 2025, then plunged by 235 bps to 110.31% in 2026.
- Business Quant data shows DTIL's FCF Margin at 110.31% in Q1 2026, 32.95% in Q4 2025, and 117461.54% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -110.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110.31% |
| Dec 31, 2025 | -32.95% |
| Sep 30, 2025 | -117,461.54% |
| Jun 30, 2025 | -112,627.78% |
| Mar 31, 2025 | -65,917.24% |
| Dec 31, 2024 | -2,943.57% |
| Sep 30, 2024 | -1,033.16% |
| Jun 30, 2024 | -29.85% |
| Mar 31, 2024 | -108.43% |
| Dec 31, 2023 | -119.31% |
| Sep 30, 2023 | -178.96% |
| Jun 30, 2023 | -112.23% |
| Mar 31, 2023 | -364.29% |
| Dec 31, 2022 | -212.07% |
| Sep 30, 2022 | 381.58% |
| Jun 30, 2022 | -654.53% |
| Mar 31, 2022 | -895.09% |
| Dec 31, 2021 | -397.32% |
| Sep 30, 2021 | -102.50% |
| Jun 30, 2021 | -48.00% |